Crescent Capital Consulting’s iShares Biotechnology ETF IBB Stock Holding History

Crescent Capital Consulting’s Portfolio IBB Stock Details IBB Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$5.82M	Buy
2021 Q3	$5.69M	Buy
2021 Q2	$4.34M	Buy
2021 Q1	$3.49M	Buy
2020 Q4	$3.01M	Buy